Bright Minds Biosciences Inc.
DRUG
Positions held
Your positionsDRUG isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $512.93M | Enterprise value | $205.17M | Trailing P/E | — | Forward P/E | -9.04 |
| PEG | — | Price / book | 2.37 | Beta | 0.23 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -13.6% | ROA | -13.5% | Debt / equity | 0.00 |
| Current ratio | 121.97 | Free cash flow | -$18.77M | Analyst recommendation | strong_buy | Mean target | $152.35 |
| 52w high | $123.75 | 52w low | $47.23 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$2.4M | -$10.5M | -$7.6M | -$4.1M | -$5.2M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$11.4M | -$15.3M | -$6.9M | -$5.7M | -$3.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$12.2M | -$2.8M | -$7.4M | -$15.0M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$13.9M | -$2.8M | -$7.4M | -$15.0M |
Headlines — positive tone
• [OK · fundamentals] All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy
News
2026-10-08 · Bright Minds Biosciences And 2 More Canadian Biotech Stocks
2026-09-30 · Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
2026-09-30 · Auxly Cannabis Group And 2 Other Canadian Biotech Stocks To Watch
2026-09-16 · 3 Small Cap Stocks With Strong Revenue Growth And Low Debt
2026-09-04 · Bright Minds Biosciences to Present at Upcoming Conferences
2026-08-27 · What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?
2026-08-10 · Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 97.4%: Read This Before Placing a Bet
2026-07-22 · All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy
Price (daily)
Full chart · RSI · MACD · patterns